Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in EUR
The 8 analysts offering 12 month price targets for Pharvaris NV have a median target of 32.29, with a high estimate of 49.67 and a low estimate of 13.91. The median estimate represents a 53.48% increase from the last price of 21.04.
High | 136.1% | 49.67 |
Med | 53.5% | 32.29 |
Low | -33.9% | 13.91 |
Earnings history & estimates in EUR
The next earnings announcement is expected on Apr 08, 2025.
Average growth rate | -11.31% |
Average growth rate | -1.37% |
More ▼
Revenue history & estimates in EUR
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼